NASDAQ:BIVV - Nasdaq -
104.98
+0.33 (+0.32%)
The current stock price of BIVV is 104.98 null. In the past month the price increased by 1.67%. In the past year, price increased by 98.11%.
Bioverativ Inc. is a biotechnology company. It focuses on the discovery, research, development, and commercialization of innovative therapies for the treatment of hemophilia and other blood disorders. Bioverativ Inc. is based in Waltham, United States.
BIOVERATIV INC
225 2ND AVENUE
WALTHAM MA 02451
CEO: John G. Cox
Phone: 781-663-4400
The current stock price of BIVV is 104.98 null. The price increased by 0.32% in the last trading session.
The exchange symbol of BIOVERATIV INC is BIVV and it is listed on the Nasdaq exchange.
BIVV stock is listed on the Nasdaq exchange.
BIOVERATIV INC (BIVV) has a market capitalization of 11.36B null. This makes BIVV a Large Cap stock.
BIOVERATIV INC (BIVV) has a support level at 104.74 and a resistance level at 104.99. Check the full technical report for a detailed analysis of BIVV support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BIVV does not pay a dividend.
The PE ratio for BIOVERATIV INC (BIVV) is 32.03. This is based on the reported non-GAAP earnings per share of 3.28 and the current share price of 104.98 null. Check the full fundamental report for a full analysis of the valuation metrics for BIVV.
ChartMill assigns a technical rating of 8 / 10 to BIVV. When comparing the yearly performance of all stocks, BIVV is one of the better performing stocks in the market, outperforming 97.96% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to BIVV. BIVV has an average financial health and profitability rating.
Over the last trailing twelve months BIVV reported a non-GAAP Earnings per Share(EPS) of 3.2774. The EPS decreased by -19.48% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 30.43% | ||
ROA | 21.97% | ||
ROE | 39.62% | ||
Debt/Equity | 0 |